Your browser doesn't support javascript.
Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020.
Kaspersen, Kathrine Agergård; Greve, Thomas; Nielsen, Kent Jacob; Jespersen, Sanne; Mikkelsen, Susan; Vestergaard, Jesper Medom; Redder, Jacob Dvinge; Tolstrup, Martin; Thomsen, Marianne Kragh; Møller, Holger Jon; Østergaard, Lars; Kolstad, Henrik Albert; Erikstrup, Christian.
  • Kaspersen KA; Department of Clinical Immunology, Aarhus University Hospital, DK-8200 Aarhus N, Denmark; Danish Big Data Centre for Environment and Health (BERTHA), Aarhus University, DK-4000 Roskilde, Denmark. Electronic address: kathkasp@rm.dk.
  • Greve T; Department of Clinical Microbiology, Aarhus University Hospital, DK-8200 Aarhus N, Denmark.
  • Nielsen KJ; Department of Occupational Medicine, Herning Regional Hospital, DK-7400 Herning, Denmark.
  • Jespersen S; Department of Infectious Diseases, Aarhus University Hospital, DK-8200 Aarhus N, Denmark.
  • Mikkelsen S; Department of Clinical Immunology, Aarhus University Hospital, DK-8200 Aarhus N, Denmark.
  • Vestergaard JM; Department of Occupational Medicine, Herning Regional Hospital, DK-7400 Herning, Denmark; Department of Occupational Medicine, Aarhus University Hospital, DK-8200 Aarhus N, Denmark.
  • Redder JD; Business Intelligence, Central Denmark Region, DK-8200 Aarhus N, Denmark.
  • Tolstrup M; Department of Infectious Diseases, Aarhus University Hospital, DK-8200 Aarhus N, Denmark.
  • Thomsen MK; Department of Clinical Microbiology, Aarhus University Hospital, DK-8200 Aarhus N, Denmark.
  • Møller HJ; Department of Clinical Biochemistry, Aarhus University Hospital, DK-8200 Aarhus N, Denmark.
  • Østergaard L; Department of Infectious Diseases, Aarhus University Hospital, DK-8200 Aarhus N, Denmark.
  • Kolstad HA; Department of Occupational Medicine, Aarhus University Hospital, DK-8200 Aarhus N, Denmark.
  • Erikstrup C; Department of Clinical Immunology, Aarhus University Hospital, DK-8200 Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University, DK-8000 Aarhus C, Denmark.
Int J Infect Dis ; 109: 17-23, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1267698
ABSTRACT

BACKGROUND:

The distribution and nature of symptoms among SARS-CoV-2 infected individuals need to be clarified.

METHODS:

Between May and August 2020, 11 138 healthcare and administrative personnel from Central Denmark Region were tested for SARS-CoV-2 antibodies and subsequently completed a questionnaire. Symptom prevalence and overall duration for symptoms persisting for more than 30 days were calculated. Logistic regression models were used to estimate adjusted odds ratios (ORs) with 95% CIs.

RESULTS:

In total, 447 (4%) of the participants were SARS-CoV-2-seropositive. Loss of sense of smell and taste was reported by 50% of seropositives compared with 3% of seronegatives. Additionally, seropositives more frequently reported fever, dyspnoea, muscle or joint ache, fatigue, cough, headache and sore throat, and they were more likely to report symptoms persisting for more than 30 days. In adjusted models, they had a higher risk of reporting symptoms, with the strongest association observed for loss of sense of taste and smell (OR = 35.6; 95% CI 28.6-44.3).

CONCLUSION:

In this large study, SARS-CoV-2-seropositive participants reported COVID-19-associated symptoms more frequently than those who were seronegative, especially loss of sense of taste and smell. Overall, their symptoms were also more likely to persist for more than 30 days.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article